According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

US pharmaceutical industry faces uncertainty with potential tariffs, impacting companies and healthcare costs, awaiting ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as they received a short-term exemption this week under President Donald Trump’s sweeping new ...

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Pharmaceutical products have long been spared from trade wars due to their potential ... The second executive at a drugmaker ...

The pharmaceutical industry isn’t happy about President Donald Trump’s trade war and is reportedly lobbying the President to slow down drug ...

The health sector faces significant instability with President Trump's tariff threats targeting Indian pharmaceutical stocks, ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking ...

US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India's pharmaceutical sector.

Minister of Health Dao Hong Lan on April 3 received a delegation led by Mr Burak Pekmezci, Country Lead of Sanofi-Aventis Vietnam Co., Ltd. The meeting was also attended by representatives from the ...